Which Strategies Should Be Implemented in Latin America to Eradicate Hepatitis C Virus by 2030?
Open Access
- 1 February 2019
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Liver Disease
- Vol. 13 (2), 43-45
- https://doi.org/10.1002/cld.771
Abstract
No abstract availableKeywords
This publication has 3 references indexed in Scilit:
- EASL Recommendations on Treatment of Hepatitis C 2018Journal of Hepatology, 2018
- Cost-effectiveness of Early Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis in a US Treatment-Naive PopulationJAMA Internal Medicine, 2016
- Cost Effectiveness of Daclatasvir/Asunaprevir Versus Peginterferon/Ribavirin and Protease Inhibitors for the Treatment of Hepatitis c Genotype 1b Naïve Patients in ChilePLOS ONE, 2015